Edgewell Personal Care Q1 sales fall 2.1% and EPS drops; GAAP outlook cut
Edgewell reported first-quarter fiscal 2025 net sales of $478.4 million, down 2.1%, and a GAAP loss of $0.04 per diluted share, versus earnings of $0.09 a year earlier. The company lowered its full-year GAAP EPS outlook to $2.54 to $2.74 from $2.59 to $2.79, citing foreign currency changes, and said adjusted EPS will be toward the lower end of its $3.15 to $3.35 range. Shareholders also voted at the February 6, 2025 annual meeting, re-electing all ten director nominees and approving the auditor and executive pay proposals.
Key points
- Net sales were $478.4 million versus $488.9 million a year earlier; organic net sales decreased 1.3%.
- GAAP diluted EPS was $(0.04) versus $0.09; adjusted EPS was $0.07 versus $0.24, including a $0.17 unfavorable currency impact.
- Full-year fiscal 2025 GAAP EPS outlook was lowered to $2.54 to $2.74 from $2.59 to $2.79; adjusted EPS is now expected toward the lower end of $3.15 to $3.35.
- At the February 6, 2025 annual meeting, all ten director nominees were elected and PricewaterhouseCoopers LLP was ratified as auditor.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 10, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.